Aaron Pelta
Corporate Officer/Principal bij MORPHIC HOLDING, INC.
Actieve functies van Aaron Pelta
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| MORPHIC HOLDING, INC. | Corporate Officer/Principal | 01-01-2019 | - |
Loopbaan van Aaron Pelta
Eerdere bekende functies van Aaron Pelta
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| X4 Pharmaceuticals (Austria) GmbH | Corporate Officer/Principal | 01-08-2016 | 01-03-2019 |
| AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | 18-06-2015 | 01-11-2015 |
Opleiding van Aaron Pelta
| Tuck School of Business at Dartmouth | Masters Business Admin |
| Tufts University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| Oostenrijk | 2 |
Operationeel
| Corporate Officer/Principal | 3 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| MORPHIC HOLDING, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
| X4 Pharmaceuticals (Austria) GmbH |
- Beurs
- Insiders
- Aaron Pelta
- Ervaring
